Written by the Nuvirox Research Team
- A 2025 meta-analysis of randomized trials concluded NMN and NR offer minimal benefit for muscle mass or strength in older adults.
- That's despite strong animal data and a compelling mechanism — a textbook example of mechanism not translating.
- An interesting newer lead: trigonelline, a different NAD+ precursor, was reduced in human sarcopenia and improved muscle function in models.
Short answer: despite a great mechanism and impressive mouse data, the human trials say NAD+ precursors do little for age-related muscle loss. If you want a clean example of why mechanism isn't enough, this is it. The story for why NAD+ should help aging muscle is excellent. The randomized human evidence, pooled and analyzed, is disappointing — and saying so plainly is the honest thing to do.
Why would NAD+ matter for aging muscle?
Sarcopenia — the progressive loss of muscle mass and strength with age — is partly a story of failing cellular energy. Muscle is mitochondria-dense and energy-hungry, NAD+ is essential to mitochondrial function, and NAD+ falls with age. In animal models, lowering muscle NAD+ causes degeneration, and restoring it with precursors can partly rescue function [1].
On paper, that makes NAD+ precursors an obvious candidate for fighting age-related muscle decline. The biology genuinely points that way, which is why the human results are such a useful corrective.
What human studies actually show
The decisive evidence: a 2025 meta-analysis came back largely negative. Researchers pooled randomized controlled trials comparing NR or NMN against placebo on measures like skeletal muscle index, handgrip strength, and gait speed in older adults. The conclusion was blunt: despite promising preclinical outcomes, the supplements offered minimal benefit for sarcopenia and muscle performance [2]. When you aggregate the actual human trials, the effect on muscle just isn't there.
Individual trials echo this. NR raised the NAD+ metabolome in aged human muscle and produced anti-inflammatory gene signatures — but didn't deliver the functional muscle gains the mechanism predicted [1]. In obese adults, NR altered some body-composition and muscle metabolite measures without translating into the dramatic outcomes seen in mice [3]. The pattern is consistent: molecular changes happen; meaningful strength and mass changes mostly don't.
One honest bright spot, though it's not the usual precursors. A 2024 study identified trigonelline — a compound found in coffee and fenugreek that the body can use as an NAD+ precursor — as reduced in people with sarcopenia, and showed it improved muscle function in experimental models [4]. That's an intriguing new direction, but it's early, and it's a different molecule from the NR and NMN in most supplements. It refines the research story; it doesn't rescue the NR/NMN muscle claim.
What NAD+ won't do
Based on current evidence, it won't build muscle, prevent age-related muscle loss, or meaningfully improve strength or gait speed in older adults — the pooled trials are clear on that. It's not a substitute for the one intervention that genuinely fights sarcopenia: resistance training, ideally with adequate protein. If you're worried about losing strength or muscle as you age, lifting and protein are where the returns are. We cover the related performance question in our piece on NAD+ and exercise performance. Significant, unexplained muscle weakness is also worth a medical check, since it can have specific causes.
Frequently asked questions
Does NAD+ help build or preserve muscle?
The pooled human evidence says no — a 2025 meta-analysis found minimal benefit of NR or NMN for muscle mass, strength, or gait speed in older adults, despite strong animal data. Resistance training and protein remain the proven approach.
Why does it work in mice but not people?
Mouse models often use conditions of extreme NAD+ depletion or stress where restoring it has dramatic effects. Healthy-aging humans aren't in that state, and the human muscle system appears to regulate NAD+ tightly. It's a common pattern across NAD+ research.
What about trigonelline I've read about?
Trigonelline is a different NAD+ precursor that showed promise in 2024 research and was found low in human sarcopenia. It's an interesting early lead but isn't the NR or NMN in typical supplements, and it's far from proven as a muscle treatment.
Should I take NAD+ if I lift weights?
If you train, the muscle benefit from an NAD+ precursor specifically isn't supported by the evidence. That doesn't mean people don't take it for other reasons, but don't expect it to add to your strength gains. The lifting is what's working.
Why we formulated NAD+ Restore
We're upfront that NAD+ Restore isn't a muscle-building product — the human trials don't support that. We make it for the cellular-health reasons NAD+ precursors are actually studied. NAD+ Restore is built around 500 mg of nicotinamide riboside chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials.
It pairs NR with 150 mg trans-resveratrol (from Japanese Knotweed) and 50 mg quercetin (from Sophora japonica) — polyphenols studied alongside NAD+ pathways for cellular health support — plus 10 mg galactomannans from fenugreek to support absorption.
It comes with a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
Learn more about NAD+ Restore →The broader lesson for NAD+ claims
Muscle is the clearest illustration of a pattern that runs through almost every NAD+ topic, so it's worth stating the general principle: mechanism predicts, but only trials confirm. The story for why NAD+ should preserve aging muscle is genuinely excellent — mitochondrial energy, sirtuin signaling, animal rescue experiments — and yet pooled human trials show minimal benefit. If a mechanism this strong can fail to translate, you should be cautious about every claim that rests on mechanism alone.
This isn't a reason to dismiss NAD+ entirely; it's a reason to demand the actual human outcome data for whatever specific benefit you're being sold. Where that data exists and is positive (a blood-pressure signal, for instance), take it seriously. Where it's absent or negative (muscle, recovery, fatigue), let that override the appealing mechanism. The trigonelline lead is worth watching, but it's a new chapter, not a vindication of the NR/NMN muscle claim.
The bottom line
NAD+ and muscle loss is the cleanest cautionary tale in this whole area: superb mechanism, strong mouse data, and a 2025 meta-analysis finding minimal human benefit for strength or mass. The molecular changes are real; the functional payoff mostly isn't. Trigonelline is an interesting new thread, but it's early and it's a different molecule. For aging muscle, resistance training and protein are the proven answer. For the related angle, see NAD+ and exercise performance and NAD+ and exercise recovery.
References
- Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Rep. 2019;28(7):1717-1728.e6. doi:10.1016/j.celrep.2019.07.043. PMID: 31412242.
- Khalil M, et al. The effect of nicotinamide mononucleotide and riboside on skeletal muscle mass and function: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2025. doi:10.1002/jcsm.13745. PMID: 40275690.
- Remie CME, Roumans KHM, Moonen MPB, et al. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans. Am J Clin Nutr. 2020;112(2):413-426. doi:10.1093/ajcn/nqaa072. PMID: 32320006.
- Membrez M, Migliavacca E, Christen S, et al. Trigonelline is an NAD+ precursor that improves muscle function during ageing and is reduced in human sarcopenia. Nat Metab. 2024;6(3):433-447. doi:10.1038/s42255-024-00997-x. PMID: 38504132.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.